Höglund P - Search Results

1

Natural killer cells in human autoimmunity.

Flodström-Tullberg M, Bryceson YT, Shi FD, Höglund P, Ljunggren HG. Flodström-Tullberg M, et al. Among authors: hoglund p. Curr Opin Immunol. 2009 Dec;21(6):634-40. doi: 10.1016/j.coi.2009.09.012. Epub 2009 Nov 4. Curr Opin Immunol. 2009. PMID: 19892538 Review.

2

Major histocompatibility complex class I-specific and -restricted killing of beta 2-microglobulin-deficient cells by CD8+ cytotoxic T lymphocytes.

Glas R, Franksson L, Ohlén C, Höglund P, Koller B, Ljunggren HG, Kärre K. Glas R, et al. Among authors: hoglund p. Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11381-5. doi: 10.1073/pnas.89.23.11381. Proc Natl Acad Sci U S A. 1992. PMID: 1454824 Free PMC article.

3

Alteration of the natural killer repertoire in H-2 transgenic mice: specificity of rapid lymphoma cell clearance determined by the H-2 phenotype of the target.

Höglund P, Glas R, Ohlén C, Ljunggren HG, Kärre K. Höglund P, et al. J Exp Med. 1991 Aug 1;174(2):327-34. doi: 10.1084/jem.174.2.327. J Exp Med. 1991. PMID: 1856626 Free PMC article.

4

Different types of allospecific CTL clones identified by their ability to recognize peptide loading-defective target cells.

Aosai F, Ohlen C, Ljunggren HG, Höglund P, Franksson L, Ploegh H, Townsend A, Kärre K, Stauss HJ. Aosai F, et al. Among authors: hoglund p. Eur J Immunol. 1991 Nov;21(11):2767-74. doi: 10.1002/eji.1830211118. Eur J Immunol. 1991. PMID: 1936122

5

Recognition of beta 2-microglobulin-negative (beta 2m-) T-cell blasts by natural killer cells from normal but not from beta 2m- mice: nonresponsiveness controlled by beta 2m- bone marrow in chimeric mice.

Höglund P, Ohlén C, Carbone E, Franksson L, Ljunggren HG, Latour A, Koller B, Kärre K. Höglund P, et al. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10332-6. doi: 10.1073/pnas.88.22.10332. Proc Natl Acad Sci U S A. 1991. PMID: 1946452 Free PMC article.

6

The RMA-S lymphoma mutant; consequences of a peptide loading defect on immunological recognition and graft rejection.

Ljunggren HG, Ohlén C, Höglund P, Franksson L, Kärre K. Ljunggren HG, et al. Among authors: hoglund p. Int J Cancer Suppl. 1991;6:38-44. doi: 10.1002/ijc.2910470711. Int J Cancer Suppl. 1991. PMID: 2066183

7

Role of major histocompatibility complex class-I molecules in tumor rejection. New insights from studies with synthetic peptides and transgenic mice.

Höglund P, Ljunggren HG, Kärre K, Jay G. Höglund P, et al. Immunol Res. 1990;9(4):298-313. doi: 10.1007/BF02935529. Immunol Res. 1990. PMID: 2089075 Review. No abstract available.

8

Empty MHC class I molecules come out in the cold.

Ljunggren HG, Stam NJ, Ohlén C, Neefjes JJ, Höglund P, Heemels MT, Bastin J, Schumacher TN, Townsend A, Kärre K, et al. Ljunggren HG, et al. Among authors: hoglund p. Nature. 1990 Aug 2;346(6283):476-80. doi: 10.1038/346476a0. Nature. 1990. PMID: 2198471

9

Effects of dimethyl sulfoxide treatment on H-2 expression and susceptibility to NK- or cytotoxic T-lymphocyte-mediated lysis of the YAC-1 lymphoma and its beta 2-microglobulin-deficient variant.

Yamasaki T, Klein G, Ljunggren HG, Höglund P, Ohlén C, Petersson MG, Kärre K. Yamasaki T, et al. Among authors: hoglund p. J Natl Cancer Inst. 1988 Apr 20;80(4):263-9. doi: 10.1093/jnci/80.4.263. J Natl Cancer Inst. 1988. PMID: 3127594

10

Natural resistance against lymphoma grafts conveyed by H-2Dd transgene to C57BL mice.

Höglund P, Ljunggren HG, Ohlén C, Ahrlund-Richter L, Scangos G, Bieberich C, Jay G, Klein G, Kärre K. Höglund P, et al. J Exp Med. 1988 Oct 1;168(4):1469-74. doi: 10.1084/jem.168.4.1469. J Exp Med. 1988. PMID: 3171481 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

441 results

Search Page